Collegium Pharmaceutical

COLL • NASDAQ •
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $144,923 $149,745 $136,709 $135,546
Gross Profit 91,456 94,630 80,311 73,826
EBITDA 84,908 101,454 86,703 78,018
EBIT 49,474 65,991 49,551 39,660
Net Income 27,713 31,940 20,634 13,007
Net Change In Cash 144,923 149,745 136,709 135,546
Cost of Revenue 12,769
Free Cash Flow 61,369 73,174 73,953 99,666
Cash 228,610 238,947 258,532 283,749
Basic Shares 41,438 41,788 42,058 42,849

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $566,767 $463,933 $276,868 $310,016
Gross Profit 326,169 209,488 150,617 179,836
EBITDA 331,832 34,366 22,218 56,464
EBIT 182,576 -104,573 -46,699 -5,086
Net Income 48,155 -25,002 71,517 26,752
Net Change In Cash 566,767 463,933 276,868 310,016
Cost of Revenue -12,738 12,310 6,644
Free Cash Flow 274,288 122,608 101,613 -279,830
Cash 238,947 173,688 186,426 174,116
Basic Shares 41,788 33,829 41,045 35,151

Earnings Calls

Quarter EPS
2024-03-31 $1.45
2023-12-31 $0.82
2023-09-30 $0.53
2023-06-30 $0.34